Results 101 to 110 of about 2,414,043 (266)
Molecular Oncology, EarlyView.This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska +13 more
wiley +1 more source
Tumor B‐cell infiltration in platinum‐treated advanced muscle‐invasive urothelial carcinoma
Molecular Oncology, EarlyView.Bladder tumors with higher pretreatment memory B‐cell infiltration were linked to longer survival after cisplatin chemotherapy, but not carboplatin. These tumors also showed more organized immune structures (tertiary lymphoid structures) and a shared pro‐inflammatory B‐cell‐rich community, suggesting that memory B cells may help identify patients most ...
Konrad Stawiski +10 more
wiley +1 more source
Defining Global Health Diplomacy: Assessing United States Global Health Diplomacy actors' knowledge, skills, and competencies. [PDF]
PLOS Glob Public HealthEsapebong-Ray F, McDonnell K, Katz R.
europepmc +1 more source
CDC's Division of Global HIV & TB presentations : World Conference on Lung Health 2016
CDC is pleased to be a part of the 47th annual Union World Conference on Lung Health alongside the world\ue2\u20ac\u2122s top scientific researchers in the field.
core
Noncommunicable Disease Unit : advancing global prevention and control [PDF]
Today, over three-quarters of all deaths worldwide are due to non-communicable diseases (NCDs). These include deaths caused by injuries, such as motor vehicle injuries, and chronic diseases, such as cardiovascular disease, cancer, diabetes, and chronic ...
core
Molecular Oncology, EarlyView.Patient‐derived organoids (PDOs) from pancreatic, colorectal, and gastric cancers were used to evaluate standard and experimental therapies. Incorporating cancer‐associated fibroblasts (CAFs) into organoid cultures improved patient therapy outcome prediction.
Marcin Grochowski +12 more
wiley +1 more source
2008 Spring Symposium on Global Health Research - April 2, 2008
, 2008 Includes descriptive metadata provided by producer in MP3 file: "Global Health - Symposia - 2008 Spring Symposium on Global Health Research - April 2, 2008." By Institute for Global ...
Ukoli, Flora A.M. +4 more
core
Loss of proton‐sensing TDAG8 increases tumor progression in mouse models of colon cancer
Molecular Oncology, EarlyView.Loss of the pH‐sensing receptor TDAG8 accelerates colorectal cancer progression in mice. Animals lacking TDAG8 expression had increased tumor growth, DNA damage, and recruitment of tumor‐associated immune cells, including macrophages, neutrophils, and monocytes.
Ermanno Malagola +11 more
wiley +1 more source
Reshaping global health architecture: African health sovereignty as the foundation of global health equity and security. [PDF]
J Public Health AfrKaseya J +10 more
europepmc +1 more source
Molecular Oncology, EarlyView.Breast cancer remains a major cause of cancer death in women, frequently developing endocrine therapy resistance. This study demonstrates that upregulated p21‐activated kinase 1 (PAK1) activity drives resistance to tamoxifen and long‐term estrogen deprivation in ER+ breast cancer models.
Luisa Schwarzmüller +10 more
wiley +1 more source